Treatment options for acne rosacea

American Family Physician

Volumn 80, Issue 5, 2009, Pages

  Goldgar, Constance ^a,b   Keahey, David J ^b   Houchins, John ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b University Physician Assistant Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; AZELAIC ACID; AZITHROMYCIN; BENZACLIN; BENZAMYCIN; BENZOYL PEROXIDE; BENZOYL PEROXIDE PLUS CLINDAMYCIN; CLARITHROMYCIN; CLINDAMYCIN; DIMETHYL SULFONE; DOXYCYCLINE; ERYTHROMYCIN; GLYCYRRHIZA EXTRACT; ISOTRETINOIN; METRONIDAZOLE; MINOCYCLINE; OXYTETRACYCLINE; PERMETHRIN; PIMECROLIMUS; PLACEBO; RETINOIC ACID; SILYMARIN; SULFACETAMIDE; SULFACETAMIDE PLUS SULFUR; SULFUR; TACROLIMUS; TETRACYCLINE; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG;

ACNE VULGARIS; APPLICATION SITE BURNING; APPLICATION SITE PRURITUS; BEDTIME DOSAGE; CANDIDA; CARBON DIOXIDE LASER; CHOLESTASIS; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE CLASSIFICATION; DRUG COST; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ELECTROSURGERY; ERYTHEMATOTELANGIECTATIC ROSACEA; ETHNICITY; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LIVER TOXICITY; LONG TERM CARE; LOW DRUG DOSE; LOW LEVEL LASER THERAPY; MOOD CHANGE; MUSCULOSKELETAL DISEASE; NEUROPATHY; NIGHT VISION; OCULAR ROSACEA; PAPULOPUSTULAR ROSACEA; PHOTOSENSITIVITY; PHYMATOUS ROSACEA; QUALITY OF LIFE; REMISSION; REVIEW; ROSACEA; SEIZURE; SIDE EFFECT; SKIN MANIFESTATION; SYSTEMIC THERAPY; TERATOGENICITY; TOPICAL TREATMENT; TREATMENT INDICATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VERTIGO;

EID: 69549114170     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002;46(4):584-587. (Pubitemid 38685771)
2. Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller A, Leffell DJ. Fitzpatrick's Dermatology in General Medicine. 7th ed. New York, NY: McGraw Hill; 2007.
3. National Rosacea Society. Rosacea review. http://www.rosacea.org/rr/2008/ spring/article-3.php. Accessed July 18, 2008.
4. Randleman JB, Loft ES, Song CD. Ocular rosacea. http://emedicine. medscape.com/article/1197341-overview. (subscription required). Accessed May 26, 2009.
5. van Zuuren EJ, Graber MA, Hollis S, Chaudhry M, Gupta AK, Gover M. Interventions for rosacea. Cochrane Database Syst Rev. 2005;(3):CD003262.
6. Powell FC. Clinical practice. Rosacea. N Engl J Med. 2005;352(8):793-803.
7. Smith SB, Smith JB. Rosacea. PIER. American College of Physicians, 2009. http://pier.acponline.org/physicians/diseases/d614/d614.html (subscription required). Accessed May 21, 2009.
8. National Rosacea Society. Rosacea triggers survey. http://www.rosacea. org/patients/materials/triggersgraph.php. Accessed May 14, 2009.
9. Katz HI, Fraser J. Lifestyle changes to manage sun exposure and other rosacea tripwires. Skin & Aging. 2003;11(10):S12-S16.
10. Del Rosso JQ. Adjunctive skin care in the management of rosacea: cleansers, moisturizers, and photoprotectants. Cutis. 2005;75(3 suppl):17-21.
11. Blount BW, Pelletier AL. Rosacea: a common, yet commonly overlooked, condition. Am Fam Physician. 2002;66(3):435-440.
12. Lonne-Rahm S, Nordlind K, Edström DW, Ros AM, Berg M. Laser treatment of rosacea: a pathoetiological study. Arch Dermatol. 2004;140(11):1345-1349. (Pubitemid 39473634)
13. Bernstein EF, Kligman A. Rosacea treatment using the new-generation, high-energy, 595 nm, long pulse-duration pulsed-dye laser. Lasers Surg Med. 2008;40(4):233-239. (Pubitemid 351628524)
14. Lebwohl MG, Medansky RS. The comparative efficacy of sodium sulfacetamide 10% sulfur 5% lotion and metronidazole 0.75% in the treatment of rosacea. J Geriatr Dermatol. 1995;3:183-185.
15. Torok HM, Webster G, Dunlap FE, Egan N, Jarratt M, Stewart D. Combination sodium sulfacetamide 10% and sulfur 5% cream with sunscreens versus metronidazole 0.75% cream for rosacea. Cutis. 2005;75(6):357-363. (Pubitemid 40905319)
16. Altinyazar HC, Koca R, Tekin NS, Estürk E. Adapalene vs. metronidazole gel for the treatment of rosacea. Int J Dermatol. 2005;44(3):252-255. (Pubitemid 40425677)
17. Berardesca E, Cameli N, Cavallotti C, Levy JL, Piérard GE, de Paoli Ambrosi G. Combined effects of silymarin and methylsulfonylmethane in the management of rosacea: clinical and instrumental evaluation. J Cosmet Dermatol. 2008;7(1):8-14. (Pubitemid 351228160)
18. Leyden JJ, Del Rosso JQ, Webster GF. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. Cutis. 2007;79(6 suppl):9-25.
19. Skidmore R, Kovach R, Walker C, et al. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch Dermatol. 2003;139(4):459-464. (Pubitemid 36427610)
20. Del Rosso JQ, Webster GF, Jackson M, et al. Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea. J Am Acad Dermatol. 2007;56(5):791-802. (Pubitemid 46561002)
21. Rigopoulos D, Kalogeromitros D, Gregoriou S, et al. Randomized placebo-controlled trial of a flavonoid-rich plant extract-based cream in the treatment of rosacea. J Eur Acad Dermatol Venereol. 2005;19(5):564-568. (Pubitemid 41742836)
22. Sanchez J, Somolinos AL, Almodóvar PI, Webster G, Bradshaw M, Powala C. A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea. J Am Acad Dermatol. 2005;53(5):791-797. (Pubitemid 41501364)
23. Knight AG, Vickers CF. A follow-up of tetracycline-treated rosacea. With special reference to rosacea keratitis. Br J Dermatol. 1975;93(5):577-580.
24. Bakar O, Demirçay Z, Gürbüz O. Therapeutic potential of azithromycin in rosacea. Int J Dermatol. 2004;43(2):151-154.
25. Akhyani M, Ehsani AH, Ghiasi M, Jafari AK. Comparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: a randomized open clinical trial. Int J Dermatol. 2008;47(3):284-288. (Pubitemid 351266852)
26. Kus S, Yucelten D, Aytug A. Comparison of efficacy of azithromycin vs. doxycycline in the treatment of acne vulgaris. Clin Exp Dermatol. 2005;30(3):215-220. (Pubitemid 40547686)
27. Nasir MA. Treatment of rosacea with tetracycline and metronidazole - a comparative study. J Pak Med Assoc. 1985;35(5):148-149. (Pubitemid 15021907)
28. Ertl GA, Levine N, Kligman AM. A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea. Arch Dermatol. 1994;130(3):319-324. (Pubitemid 24107870)
29. Jansen T, Plewig G. Clinical and histological variants of rhinophyma, including nonsurgical treatment modalities. Facial Plast Surg. 1998;14(4):241-253. (Pubitemid 29474183)
30. Kligman AM. Ocular rosacea. Current concepts and therapy. Arch Dermatol. 1997;133(1):89-90. (Pubitemid 27044310)
31. Borrie P. Rosacea with special reference to its ocular manifestations. Br J Dermatol. 1953;65(12):458-463.
32. Frucht-Pery J, Sagi E, Hemo I, Ever-Hadani P. Efficacy of doxycycline and tetracycline in ocular rosacea. Am J Ophthalmol. 1993;116(1):88-92. (Pubitemid 23198489)